Insider Transactions in Q2 2023 at Eli Lilly & CO (LLY)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
164,125
-0.03%
|
$76,646,375
$467.45 P/Share
|
|
Jun 29
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
44,115
-0.04%
|
$20,513,475
$465.08 P/Share
|
|
Jun 28
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
11,760
-0.01%
|
$5,468,400
$465.78 P/Share
|
|
Jun 22
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
107,022
-0.01%
|
$49,016,076
$458.99 P/Share
|
|
Jun 21
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
31,454
-0.02%
|
$14,280,116
$454.54 P/Share
|
|
Jun 20
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.98%
|
$9,471
$451.95 P/Share
|
|
Jun 20
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.21%
|
$14,432
$451.95 P/Share
|
|
Jun 20
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.65%
|
$4,961
$451.95 P/Share
|
|
Jun 20
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.03%
|
$9,922
$451.95 P/Share
|
|
Jun 20
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+2.2%
|
$9,922
$451.95 P/Share
|
|
Jun 20
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.05%
|
$11,275
$451.95 P/Share
|
|
Jun 20
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
34,156
-0.03%
|
$15,506,824
$454.08 P/Share
|
|
Jun 16
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
25,015
-0.01%
|
$11,381,825
$455.53 P/Share
|
|
Jun 15
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
27,353
-0.01%
|
$12,418,262
$454.59 P/Share
|
|
Jun 15
2023
|
Johna Norton EVP, Global Quality |
SELL
Open market or private sale
|
Direct |
1,647
-5.19%
|
$737,856
$448.0 P/Share
|
|
Jun 14
2023
|
Johna Norton EVP, Global Quality |
SELL
Open market or private sale
|
Direct |
1,647
-4.93%
|
$731,268
$444.29 P/Share
|
|
Jun 01
2023
|
Diogo Rau EVP & CIDO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,848
-26.63%
|
$1,221,792
$429.46 P/Share
|
|
Jun 01
2023
|
Diogo Rau EVP & CIDO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+37.07%
|
-
|
|
Jun 01
2023
|
Patrik Jonsson EVP&Pres, LLY Dia&Obe, LLY USA |
SELL
Open market or private sale
|
Direct |
6,000
-13.97%
|
$2,574,000
$429.46 P/Share
|
|
May 19
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
194,354
-0.03%
|
$86,293,176
$444.91 P/Share
|
|
May 15
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.66%
|
$4,774
$434.51 P/Share
|
|
May 15
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
600
-9.12%
|
$261,000
$435.29 P/Share
|
|
May 15
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+1.04%
|
$9,548
$434.51 P/Share
|
|
May 15
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.22%
|
$14,322
$434.51 P/Share
|
|
May 15
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.05%
|
$11,284
$434.51 P/Share
|
|
May 15
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.03%
|
$9,982
$434.51 P/Share
|
|
May 15
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+2.36%
|
$9,982
$434.51 P/Share
|
|
May 12
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
20,646
-0.01%
|
$9,146,178
$443.29 P/Share
|
|
May 03
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
178,302
-0.01%
|
$75,778,350
$425.09 P/Share
|
|
May 02
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
41,698
-0.01%
|
$17,054,482
$409.66 P/Share
|
|
Apr 28
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
225,000
-0.02%
|
$89,775,000
$399.57 P/Share
|
|
Apr 17
2023
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.01%
|
$1,860
$372.35 P/Share
|
|
Apr 17
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
26
+1.24%
|
$9,672
$372.35 P/Share
|
|
Apr 17
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
39
+0.26%
|
$14,508
$372.35 P/Share
|
|
Apr 17
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.78%
|
$4,836
$372.35 P/Share
|
|
Apr 17
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.06%
|
$11,160
$372.35 P/Share
|
|
Apr 17
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+0.04%
|
$10,044
$372.35 P/Share
|
|
Apr 17
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
27
+2.82%
|
$10,044
$372.35 P/Share
|
|
Apr 06
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
130,297
-0.02%
|
$47,818,999
$367.21 P/Share
|
|
Apr 05
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
69,703
-0.03%
|
$25,302,189
$363.72 P/Share
|
|
Apr 03
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.07%
|
$73,500,000
$350.79 P/Share
|